Sodium clodronate - Malignancy
You are here : Home > Formulary Search > Sodium clodronate - Malignancy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Sodium clodronate
Indication :
Malignancy
Group Name :
Keywords :
hypercalcaemia of malignancy, bone metastases, prevention of skeletal events
Brand Names Include :
Bonefos, Loron, Clasteon
Important Information :
Hypercalcaemia of malignancy. Bone metastases. Prevention of skeletal events.
Initiation and stabilisation for a minimum of 3 months by specialist team before any request for primary care prescribing.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Sodium clodronate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Malignancy.
Committee Recommendations (0)
- No records returned.